TNF Pharmaceuticals
Cash Flow
Last updated:
Cash flow statement presents a set of outflows and inflows of cash within a company through operating, investing and financing activities. Over the last year, operating activities of TNF Pharmaceuticals generated cash of -$12,980,625, which is less than the previous year. Cash used in financing activities reached the amount of $13,066,819 last year. Net change in cash is therefore $1,931,920.
Cash Flow
| 2015 | -5.13M | 5.07M | 0 |
|---|---|---|---|
| 2017 | -5.08M | -5.01M | 10.46M |
| 2019 | -3.07M | -3.94M | 6.96M |
| 2022 | -12.27M | 6.91M | 5.55M |
| 2023 | -12.98M | 1.84M | 13.06M |
TNFA Cash Flow Statement (2015 – 2023)
| 2023 | 2022 | 2019 | 2017 | 2015 | |
|---|---|---|---|---|---|
Cash at beginning of period | 749.09K | 555.96K | 181.75K | 72.7K | 455.84K |
Operating activities | |||||
Net income | -3.99M | -15.19M | -3.38M | -7.36M | -9.31M |
| Adjustments to reconcile net income to cash generated by operating activities: | |||||
Depreciation and amortization | 0 | 0 | 74.06K | 249.89K | 299.99K |
Stock-based compensation expense | 3.04M | 695.19K | 3.57M | 0 | 0 |
| Deferred income tax benefit | 3.04M | 695.19K | 3.57M | 0 | 0 |
| Changes in operating assets and liabilities: | |||||
Accounts receivable, net | 0 | 0 | 128.12K | -781.50K | 635.59K |
Inventories | 0 | 0 | 14.28K | -119.61K | -226.53K |
Accounts payable | 1.04M | 1.68M | -443.73K | 87.60K | 827.60K |
Cash generated by operating activities | -12.98M | -12.27M | -3.07M | -5.08M | -5.13M |
Investing activities | |||||
Purchases Of Investments | -13.45M | -4.83M | -6.70M | -7.70M | -125.03K |
Investments In Property Plant And Equipment | 0 | 0 | 0 | -54.50K | -112.95K |
Acquisitions Net | 0 | 0 | 6.25K | 0 | 0 |
Cash generated by investing activities | 1.84M | 6.91M | -3.94M | -5.01M | 5.07M |
Financing activities | |||||
Common Stock Issued | 0 | 5.55M | 6.96M | 10.46M | 0 |
Payments for dividends | -1.45M | 0 | 0 | 0 | 0 |
Repurchases of common stock | 0 | 0 | 0 | 0 | 0 |
Repayments of term debt | 0 | 0 | 1.92M | 0 | 0 |
Cash used in financing activities | 13.06M | 5.55M | 6.96M | 10.46M | 0 |
Net Change In Cash | 1.93M | 193.12K | 335.68K | 365.73K | 0 |
Cash at end of period | 2.68M | 749.09K | 517.44K | 438.43K | 402.05K |